Beijing Fengtai Hospital of Integrated Traditional and Western Medicine Report issue

Academic/Hospital Phase 2

Organization Overview

First Clinical Trial
2019
NCT03709849
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Alternative names

Beijing Fengtai Hospital of Integrated Traditional and Western Medicine

Active Ingredients

Drugs in Phase 2 Trials (2)

bushen culuan (1 trial)

clomifene (clomid) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Anovulation (Phase 2)

Hyperprolactinemia (Phase 2)

Infertility (Phase 2)

Polycystic Ovary Syndrome (Phase 2)

Syndrome (Phase 2)

Uterine Hemorrhage (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 1
  • # of Trial APIs: 2